Pfizer's New Lyme Vaccine Shows 70% Effectiveness in Trials

After more than 20 years without a Lyme disease vaccine in the U.

, Pfizer's new four-dose vaccine shows promising results that could protect millions from the most common tick-borne illness in America.

The vaccine, tested across thousands of people in the U.